Neurexan (Avena Sativa D2, Passiflora Incarnata D2, Zincum Isovalerianicum D4, Coffea Arabica D12)

Avena sativa, present as a homeopathic dilution, is thought to act through the body's self‑regulatory pathways. The ingredient may influence neuronal excitability and help balance neurotransmitter activity, contributing to a gentle calming effect without direct receptor binding.

The appropriate dose of Neurexan is determined by a qualified healthcare professional based on the individual’s condition, age, and overall health. Patients should follow the prescriber’s instructions and not alter the regimen without medical advice.

Safety data for Neurexan in pregnancy and lactation are limited. It is generally advised to avoid use unless the potential benefit justifies the potential risk and a physician has evaluated the situation.

To order Neurexan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike conventional anxiolytics such as benzodiazepines, Neurexan is a homeopathic preparation that does not contain pharmacologically active concentrations of active substances. It is generally considered for mild symptoms and has a different safety profile, with fewer sedative effects but limited clinical evidence compared with prescription agents.

Neurexan tablets should be stored at ambient temperature below 25 °C, in the original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and avoid storing in bathrooms or other humid environments.

Neurexan is taken orally as a tablet. The tablet is swallowed whole with water, usually as directed by a healthcare professional. It is not intended for sublingual or chewable use.

Serious but rare risks include allergic reactions such as rash, itching, swelling of the face or throat, and anaphylaxis. If any signs of severe hypersensitivity occur, the product should be discontinued immediately and medical attention sought.

Neurexan should be avoided by individuals with known hypersensitivity to any of its ingredients, by those taking strong CNS depressants without medical supervision, and by pregnant or breastfeeding women unless a physician determines that the benefit outweighs the risk.